The Multiple Sclerosis Association of America (MSAA) Focuses on Improving Mental Health and Wellness in Honor of MS Awareness Month

The Multiple Sclerosis Association of America (MSAA) recognizes March as Multiple Sclerosis (MS) Awareness Month. MSAA is proud to announce the 2021 awareness campaign theme on Improving Mental Health and Wellness, with specific programs addressing Purpose in Life, depression and anxiety in MS, care partnering, and wellness strategies to improve symptom management and overall quality […]

Read News Article

What’s New in MS Research: January 2021

The expression, “Here’s hoping this year is better than the last” has particular poignancy as we transition into 2021. Happily, much of the recent news regarding multiple sclerosis (MS) provides cause for considerable hope, as reflected in the study results and other reports featured in this month’s iteration of “What’s New in MS Research.”

Read News Article

Impact Education, LLC and MSAA Release New Whitepaper on Payer Considerations for Providing Support to People With MS and Their Care Partners

BLUE BELL, Pa.–(BUSINESS WIRE)–Impact Education, LLC (IMPACT) and the Multiple Sclerosis Association of America (MSAA) announce the release of a new whitepaper based on key findings from a series of dynamic roundtable discussions between payers and multiple sclerosis (MS) healthcare providers. MS affects about 1,000,000 people in the United States and while quality care is […]

Read News Article

What’s New in MS Research – November 2020

While we all know “MS” stands for “multiple sclerosis,” with so much exciting research reported in this edition of “What’s New in MS Research,” we can almost imagine that “MS” could also refer to the quest for “multiple solutions” in MS. Although a great deal of the research looks to further understand the biology, easing the symptoms, and slowing or stopping the physical damage of MS, the studies and other information presented here are very encouraging – and they are only a small sample of the vast array of research under way around the world.

Read News Article

What’s New in MS Research: September 2020

This edition of MSAA’s “What’s New in MS Research” article features highlights from the annual meetings of the American Academy of Neurology (AAN) and the Consortium of MS Centers (CMSC). Because of the ongoing COVID-19 pandemic, both of these meetings were held virtually. While not all of the reports are positive, the good far outweighs the rest, and encompasses not only promising research advances in MS, but also a potential role for a long-established DMT in treating COVID-19.

Read News Article

FDA Approves Kesimpta® (Ofatumumab), the First Self-Administered B-cell Therapy for Relapsing Forms of MS

Updated September 3, 2020 Reviewed by MSAA Chief Medical Officer Barry A. Hendin, MD On August 20, 2020, Novartis announced that the United States Food and Drug Administration (FDA) approved Kesimpta® (ofatumumab) for adults with relapsing forms of multiple sclerosis (RMS), which includes clinically isolated syndrome, relapsing-remitting disease, and active secondary-progressive disease. Kesimpta is a […]

Read News Article

FDA Approves Generic Version of Tecfidera®, Taken Orally for MS

Reviewed by MSAA Chief Medical Officer Barry A. Hendin, MD On August 17, 2020, the United States Food and Drug Administration (FDA) awarded early approval of Mylan’s generic version of Biogen’s Tecfidera® (dimethyl fumarate), an oral medication approved in 2013 for relapsing forms of MS in adults. Mylan announced the launch of this generic medication […]

Read News Article

MSAA’s Publications, Website, and Blog Receive National Recognition

The Multiple Sclerosis Association of America (MSAA) is proud to announce that many of our free publications and resources received awards this summer from the APEX Awards for Publication Excellence, the Digital Health Awards, the National Health Information Awards, and Healthline! MSAA received four Awards of Excellence from the Thirty-Second Annual APEX Awards! The first […]

Read News Article

The Multiple Sclerosis Association of America and Wondros Launch COVID-19 and MS Pathfinder

In an effort to provide accurate and easily accessible information about the ongoing COVID-19 pandemic, the Multiple Sclerosis Association of America (MSAA) and Wondros are proud to announce the creation of the COVID-19 and MS Pathfinder online tool, available on MSAA’s website at https://mymsaa.org/covid-19-and-ms-pathfinder/. The COVID-19 and MS Pathfinder tool allows members of the multiple […]

Read News Article

Statement from MSAA

The Multiple Sclerosis Association of America advocates equally for all members of the MS community, and supports all peaceful efforts aimed at erasing the inequalities that exist between people of different races, religions, gender, and economic backgrounds, as well as those with disabilities. MSAA recognizes the inequities and overwhelming pain associated with discrimination and senseless acts of injustice.

Read News Article